Five years ago we began a monthly journal aimed at primary care doctors in the United States. BMJ USA comprised articles selected from the weekly BMJ by a US based editor, along with commissioned commentaries and editorials. Despite the journal's popularity with readers, we couldn't attract sufficient support from the US pharmaceutical market, and last month's issue was the last.

This week we start “US highlights”—assembled on the same principle as the print journal BMJ USA—but available solely in electronic form from the BMJ's website (http://bmj.com/us_highlights). The fact that BMJ USA's editor, …